Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 3
2005 5
2006 5
2007 11
2008 6
2009 4
2010 7
2011 6
2012 4
2013 10
2014 12
2015 4
2016 6
2017 9
2018 4
2019 3
2020 9
2021 9
2022 7
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Performance of a Region of Interest-based Algorithm in Diagnosing International Society of Urological Pathology Grade Group ≥2 Prostate Cancer on the MRI-FIRST Database-CAD-FIRST Study.
Couchoux T, Jaouen T, Melodelima-Gonindard C, Baseilhac P, Branchu A, Arfi N, Aziza R, Barry Delongchamps N, Bladou F, Bratan F, Brunelle S, Colin P, Correas JM, Cornud F, Descotes JL, Eschwege P, Fiard G, Guillaume B, Grange R, Grenier N, Lang H, Lefèvre F, Malavaud B, Marcelin C, Moldovan PC, Mottet N, Mozer P, Potiron E, Portalez D, Puech P, Renard-Penna R, Roumiguié M, Roy C, Timsit MO, Tricard T, Villers A, Walz J, Debeer S, Mansuy A, Mège-Lechevallier F, Decaussin-Petrucci M, Badet L, Colombel M, Ruffion A, Crouzet S, Rabilloud M, Souchon R, Rouvière O. Couchoux T, et al. Among authors: colombel m. Eur Urol Oncol. 2024 Mar 15:S2588-9311(24)00056-7. doi: 10.1016/j.euo.2024.03.003. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38493072 Free article.
Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer.
Catto JWF, Tran B, Rouprêt M, Gschwend JE, Loriot Y, Nishiyama H, Redorta JP, Daneshmand S, Hussain SA, Cutuli HJ, Procopio G, Guadalupi V, Vasdev N, Naini V, Crow L, Triantos S, Baig M, Steinberg G; THOR-2 Cohort 1 Investigators. Catto JWF, et al. Ann Oncol. 2024 Jan;35(1):98-106. doi: 10.1016/j.annonc.2023.09.3116. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871701 Free article. Clinical Trial.
Zone-specific computer-aided diagnosis system aimed at characterizing ISUP ≥ 2 prostate cancers on multiparametric magnetic resonance images: evaluation in a cohort of patients on active surveillance.
Arber T, Jaouen T, Campoy S, Rabilloud M, Souchon R, Abbas F, Moldovan PC, Colombel M, Crouzet S, Ruffion A, Neuville P, Rouvière O. Arber T, et al. Among authors: colombel m. World J Urol. 2023 Dec;41(12):3527-3533. doi: 10.1007/s00345-023-04643-1. Epub 2023 Oct 17. World J Urol. 2023. PMID: 37845554
Quality of Life in Patients with High-grade Non-muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial.
van Straten CGJI, Caris C, Grimm MO, Colombel M, Muilwijk T, Martínez-Piñeiro L, Babjuk MM, Türkeri LN, Palou J, Patel A, Bjartell AS, Witjes WPJ, van der Heijden AG, Kiemeney LALM. van Straten CGJI, et al. Among authors: colombel m. Eur Urol Open Sci. 2023 Sep 12;56:15-24. doi: 10.1016/j.euros.2023.08.004. eCollection 2023 Oct. Eur Urol Open Sci. 2023. PMID: 37822514 Free PMC article.
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial.
Lebret T, Paoletti X, Pignot G, Roumiguié M, Colombel M, Savareux L, Verhoest G, Guy L, Rigaud J, De Vergie S, Poinas G, Droupy S, Kleinclauss F, Courtade-Saïdi M, Piaton E, Radulescu C, Rioux-Leclercq N, Kandel-Aznar C, Renaudin K, Cochand-Priollet B, Allory Y, Nivet S, Rouprêt M. Lebret T, et al. Among authors: colombel m. World J Urol. 2023 Sep;41(9):2381-2388. doi: 10.1007/s00345-023-04519-4. Epub 2023 Jul 22. World J Urol. 2023. PMID: 37480491 Free PMC article.
Characterization of high-grade prostate cancer at multiparametric MRI using a radiomic-based computer-aided diagnosis system as standalone and second reader.
Jaouen T, Souchon R, Moldovan PC, Bratan F, Duran A, Hoang-Dinh A, Di Franco F, Debeer S, Dubreuil-Chambardel M, Arfi N, Ruffion A, Colombel M, Crouzet S, Gonindard-Melodelima C, Rouvière O. Jaouen T, et al. Among authors: colombel m. Diagn Interv Imaging. 2023 Oct;104(10):465-476. doi: 10.1016/j.diii.2023.04.006. Epub 2023 May 20. Diagn Interv Imaging. 2023. PMID: 37345961 Free article.
TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization.
Thierry S, Maadadi S, Berton A, Dimier L, Perret C, Vey N, Ourfali S, Saccas M, Caron S, Boucard-Jourdin M, Colombel M, Werle B, Bonnin M. Thierry S, et al. Among authors: colombel m. Microb Cell. 2023 Apr 19;10(6):117-132. doi: 10.15698/mic2023.06.797. eCollection 2023 Jun 5. Microb Cell. 2023. PMID: 37275475 Free PMC article.
Characterization of high-grade prostate cancer at multiparametric MRI: assessment of PI-RADS version 2.1 and version 2 descriptors across 21 readers with varying experience (MULTI study).
Di Franco F, Souchon R, Crouzet S, Colombel M, Ruffion A, Klich A, Almeras M, Milot L, Rabilloud M, Rouvière O; MULTI Study Group. Di Franco F, et al. Among authors: colombel m. Insights Imaging. 2023 Mar 20;14(1):49. doi: 10.1186/s13244-023-01391-z. Insights Imaging. 2023. PMID: 36939970 Free PMC article.
116 results